Back to top
more

Baxter International (BAX)

(Real Time Quote from BATS)

$36.36 USD

36.36
1,513,559

-0.55 (-1.49%)

Updated Oct 2, 2024 12:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International

Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International

Here's Why You Should Retain Patterson Companies (PDCO) Now

Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.

Abbott's (ABT) FreeStyle Libre Gains Canadian Reimbursement

With this reimbursement approval, Abbott's (ABT) FreeStyle Libre becomes the first sensor-based glucose monitoring system to be listed by any provincial health plan in Canada.

Medtronic (MDT) Earns Dow Jones Sustainability Recognition

Medtronic's (MDT) strong ESG practices facilitate inclusion in the North American Dow Jones Sustainability Index.

BioSig Technologies-Mayo Clinic Ink Electrophysiology Deal

This collaboration is expected to bolster BioSig's (BSGM) commitment toward offering higher quality patient care by introducing innovative technological solutions to medicine.

Walgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes

Walgreens' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also gaining traction from a solid retail prescription market.

BAX or BSX: Which Is the Better Value Stock Right Now?

BAX vs. BSX: Which Stock Is the Better Value Option?

CryoLife Enters Agreement With Endospan for Aortic Stent

CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.

Medidata (MDSO) Collaborates With Mapi Research to Boost Rave

Medidata's (MDSO) latest collaboration is expected to solve major eCOA implementation struggles in the pharmaceutical industry.

Ecolab's (ECL) Nalco Water Opens Customer Experience Center

Ecolab (ECL) expects Nalco's water technologies to reduce freshwater usage by 20%.

Here's Why You Should Hold on to Ecolab (ECL) Stock Now

Ecolab (ECL) continues to gain from robust product portfolio and strong international presence. However, forex remains a woe.

5 High-Flying Stocks Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

Bruker (BRKR) Introduces the nanoIR3-s Broadband System

The launch of the FTIR spectroscopy system complements Bruker's (BRKR) target to boost its portfolio of nanoIR products.

Integra Buys Rebound Therapeutics to Boost Neurosurgery Line

Integra (IART) believes, Rebound's MIS technological arm will widen its neurosurgical pipeline within Codman Specialty Surgical space.

Baxter's (BAX) Cheetah Acquisition to Aid Patient Monitoring

Baxter (BAX) expects this deal to remain neutral to its earnings in 2019 and 2020.

GNC Holdings Rides on New Pacts Amid Weak Same Store Sales

GNC Holdings' (GNC) recent joint venture with vitamins and nutritional supplement manufacturer International Vitamin Corporation shows high prospects at present.

Medtronic's (MDT) MiniMed 670G Gains German Reimbursement

Medtronic's (MDT) MiniMed 670G is witnessing a solid uptake in the United States ever since its launch last year.

Medtronic's (MDT) IN.PACT AV Access Study Results Bode Well

The results of the study will prove to be a major stride for Medtronic (MDT) to treat patient suffering from renal diseases.

Here's Why You Should Invest in Intuitive Surgical (ISRG) Now

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base.

Masimo (MASI) Boosts O3 Platform With Three New Indices

Masimo (MASI) announced the development of three additional indices for O3 Regional Oximetry, thereby improving the O3 platform.

Zimmer Biomet (ZBH) Launches Persona Revision for Knee Care

Zimmer Biomet (ZBH) prepares for the commercial launch of improvised knee replacement procedures through its flagship program, Persona Revision Knee System.

Illumina Banks on New Product Suite Despite Margin Woes

The unveiling of Veriseq NIPT v2 and Illumina's (ILMN) alliance with AnchorDx in the second quarter further raise investor confidence in the stock.

Abbott (ABT) Launches Pivotal Trial TRILUMINATE in the US

Given the lack of an alternative therapy to replace tricuspid regurgitation surgery, Abbott (ABT) should be at an advantage in this space.

Aurora Cannabis (ACB) to Report Q4 Earnings: What's in Store?

Cannabis revenue growth and improved gross margin are likely to aid Aurora Cannabis (ACB) in Q4 earnings.

Here's Why You Should Retain NextGen Healthcare Stock Now

NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.